Author： Smith L. Andersen K.B. Hovgaard L. Jaroszewski J.W.
Publisher： Elsevier
ISSN： 0928-0987
Source： European Journal of Pharmaceutical Sciences, Vol.11, Iss.3, 2000-09, pp. : 191-198
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Antisense oligonucleotide therapeutics
By Bennett C.F.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. :
Antisense Anticancer Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. :
Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design, Vol. 10, Iss. 7, 2004-03 ,pp. :
Antisense and / or Immunostimulatory Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. :